SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5.23 |
| Enterprise Value ($M) | 26.48 |
| Book Value ($M) | -28.73 |
| Book Value / Share | -3.46 |
| Price / Book | -0.18 |
| NCAV ($M) | -86.16 |
| NCAV / Share | -10.39 |
| Price / NCAV | -0.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.91 |
| Return on Equity (ROE) | -5.19 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.09 |
| Current Ratio | 0.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.04 |
| Assets | 59.46 |
| Liabilities | 88.19 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Zurcher Kantonalbank (Zurich Cantonalbank) | 6.80 | ||
| 13D | Bruhlmann Christian | 5.23 | ||
| 13D | Schiess Ralph | 5.98 | ||
| 13G | New Horizon Health Ltd | 6.91 | ||
| 13D | Altos Venture AG | 32.50 | 144.33 | |
| 13G/A | Hernandez Joseph | 0.00 | -100.00 | |
| 13G/A | American Financial Group Inc | 7.70 | 53.17 | |
| 13G/A | Sabby Management, Llc | 4.99 | -23.11 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 36,604 | 122,258 | 29.94 | |
| 60,968 | 316,629 | 19.26 | |
| 56,725 | 238,478 | 23.79 | |
| 10,154 | 68,235 | 14.88 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OCGN – Ocugen, Inc. | OCX – OncoCyte Corporation |
| OKYO – OKYO Pharma Limited | ONCT – Oncternal Therapeutics, Inc. |
| ONCY – Oncolytics Biotech Inc. |
Financial data and stock pages provided by
Fintel.io